Ajax-Loading

Roche Holding AG - Ebitda

Roche Holding AG's Fiscal Year is From January To December - All Figures are in CHF, Billions.

The item "Ebitda" stands at 12.50 Billion Swiss Francs for the trailing twelve months (TTM) period ending 06/30/2025, the lowest value at least since 12/31/2011, the period currently displayed.'
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -28.95 percent compared to the value the year prior.
The 1 year change in percent is -28.95.
The 3 year change in percent is -45.69.
The 5 year change in percent is -41.60.
The 10 year change in percent is -53.86.

The Serie's long term average value is 23.92 Billion Swiss Francs. It's latest available value, on 06/30/2025, is 47.72 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2025, to it's latest available value, on 06/30/2025, is +0.0%.
The Serie's change in percent from it's maximum value, on 03/31/2023, to it's latest available value, on 06/30/2025, is -61.30%.

Ebitda for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Ebitda905,699,262,464.00
LogoJohnson & Johnson - Ebitda486,508,953,600.00
LogoAbbVie Inc - Ebitda399,570,305,024.00
LogoAstraZeneca PLC - Ebitda280,205,508,085.11
LogoNovartis AG - Ebitda255,096,620,580.91